dear_xiaokuan
Lv12
92 积分
2025-01-27 加入
-
Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority Trial
19小时前
求助中
-
Selective Elimination of Breast Surgery for Invasive Breast Cancer
19小时前
已完结
-
Selective elimination of surgery for early invasive breast cancer: promise, challenges, and prospects
19小时前
已关闭
-
Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial
19小时前
已完结
-
Abstract PR010: Preliminary safety and pharmacokinetic profiles of RMC-6236, a first-in-class, RAS-selective, tri-complex RASMULTI(ON) inhibitor in patients with KRAS mutant solid tumors on the Phase 1 trial RMC-6236-001
4天前
已关闭
-
A successful collaboration between academia, biotech and pharma led to discovery of erdafitinib, a selective FGFR inhibitor recently approved by the FDA
2个月前
已完结
-
Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin
4个月前
已完结
-
Reaction of Diisobutylaluminum Borohydride, a Binary Hydride, with Selected Organic Compounds Containing Representative Functional Groups
6个月前
已完结
-
Development of Cyanopyridazine Derivatives as Photoredox Catalysts and Evaluation of their Catalytic Performance
6个月前
已完结
-
Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 Mpro from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants
6个月前
已完结